Invited commentary: Author's response to "CRS and HIPEC: Best model of antifragility in surgical oncology".

Abstract

Journal of Surgical OncologyVolume 126, Issue 2 p. 398-399 LETTER TO THE EDITOR Invited commentary: Author's response to “CRS and HIPEC: Best model of antifragility in surgical oncology” Christopher W. Mangieri MD, Corresponding Author Christopher W. Mangieri MD [email protected] Division of Surgical Oncology, Wake Forest Baptist Health Medical Center, Winston-Salem, North Carolina, USA Correspondence Christopher W. Mangieri, MD, Department of Surgery, Surgical Oncology Section, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA. Email: [email protected]Search for more papers by this author Christopher W. Mangieri MD, Corresponding Author Christopher W. Mangieri MD [email protected] Division of Surgical Oncology, Wake Forest Baptist Health Medical Center, Winston-Salem, North Carolina, USA Correspondence Christopher W. Mangieri, MD, Department of Surgery, Surgical Oncology Section, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA. Email: [email protected]Search for more papers by this author First published: 23 April 2022 https://doi.org/10.1002/jso.26904Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume126, Issue2August 1, 2022Pages 398-399 RelatedInformation